[Detection of causative bacteria for bovine mastitis and their susceptibility to beta-lactam antibacterial agents]. 1990

S Kamata, and T Matsunaga, and K Uchida, and K Uchida
Department of Veterinary Hygiene, Nippon Veterinary and Zootechnical College.

During the period from November 1988 to May 1989, causative bacteria in a total of 172 clinical mastitis cases observed in 66 farms in 5 districts with 6 areas in Japan were examined and frequencies of their occurrences were determined. Susceptibilities (in MICs) of the isolates to 6 beta-lactam antibacterial agents were also determined. As a result, coagulase-negative staphylococci (CNS) was identified in 94 out of 172 cases (54.7%) and were the most prevalent. Corynebacterium spp., Gram-negative bacteria and Staphylococcus aureus were found in 52 (30.2%), 49 (28.5%) and 43 (25.0%) cases, respectively. Four species of Streptococcus family (S. agalactiae, S. dysgalactiae, S. uberis and S. bovis) were identified in a total of 58 cases (33.7%). Susceptibility testing of CNS to cefoperazone (CPZ), cefazolin (CEZ), benzylpenicillin (PCG), ampicillin (ABPC), methicillin (DMPPC) and cloxacillin (MCIPC) showed that all MIC80's (inhibiting bacterial growth of 80% of all isolates) were within a range from 0.10 to 3.13 micrograms/ml and that there was no marked differences in antibacterial effects among the antibiotics used. The highest antibacterial effect on S. aureus was exhibited by MCIPC, which inhibited the growth of all isolates at 0.39 microgram/ml. The MICs of DMPPC against all isolates of S. aureus were 3.13 micrograms/ml or less and no methicillin-resistant S. aureus (MRSA) was detected. There was no difference in antibacterial activities against Streptococcus family between penicillin antibiotics (DMPPC, MCIPC, ABPC and PCG) and cephem antibiotics (CPZ and CEZ), both of which showed excellent antibacterial activities. Cephem antibiotics exhibited higher activities against Gram-negative bacteria than penicillin antibiotics. Especially CPZ, the third generation cephem, showed excellent antibacterial activity against Escherichia coli, Klebsiella spp., Enterobacter spp., as well as against other Enterobacteriaceae.

UI MeSH Term Description Entries
D008414 Mastitis, Bovine INFLAMMATION of the UDDER in cows. Bovine Mastitides,Bovine Mastitis,Mastitides, Bovine
D002417 Cattle Domesticated bovine animals of the genus Bos, usually kept on a farm or ranch and used for the production of meat or dairy products or for heavy labor. Beef Cow,Bos grunniens,Bos indicus,Bos indicus Cattle,Bos taurus,Cow,Cow, Domestic,Dairy Cow,Holstein Cow,Indicine Cattle,Taurine Cattle,Taurus Cattle,Yak,Zebu,Beef Cows,Bos indicus Cattles,Cattle, Bos indicus,Cattle, Indicine,Cattle, Taurine,Cattle, Taurus,Cattles, Bos indicus,Cattles, Indicine,Cattles, Taurine,Cattles, Taurus,Cow, Beef,Cow, Dairy,Cow, Holstein,Cows,Dairy Cows,Domestic Cow,Domestic Cows,Indicine Cattles,Taurine Cattles,Taurus Cattles,Yaks,Zebus
D003352 Corynebacterium A genus of asporogenous bacteria that is widely distributed in nature. Its organisms appear as straight to slightly curved rods and are known to be human and animal parasites and pathogens.
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001424 Bacterial Infections Infections by bacteria, general or unspecified. Bacterial Disease,Bacterial Infection,Infection, Bacterial,Infections, Bacterial,Bacterial Diseases
D013210 Staphylococcus A genus of gram-positive, facultatively anaerobic, coccoid bacteria. Its organisms occur singly, in pairs, and in tetrads and characteristically divide in more than one plane to form irregular clusters. Natural populations of Staphylococcus are found on the skin and mucous membranes of warm-blooded animals. Some species are opportunistic pathogens of humans and animals.
D013291 Streptococcus A genus of gram-positive, coccoid bacteria whose organisms occur in pairs or chains. No endospores are produced. Many species exist as commensals or parasites on man or animals with some being highly pathogenic. A few species are saprophytes and occur in the natural environment.
D047090 beta-Lactams Four-membered cyclic AMIDES, best known for the PENICILLINS based on a bicyclo-thiazolidine, as well as the CEPHALOSPORINS based on a bicyclo-thiazine, and including monocyclic MONOBACTAMS. The BETA-LACTAMASES hydrolyze the beta lactam ring, accounting for BETA-LACTAM RESISTANCE of infective bacteria. beta-Lactam,4-Thia-1-Azabicyclo(3.2.0)Heptanes,4-Thia-1-Azabicyclo(4.2.0)Octanes,beta Lactam,beta Lactams

Related Publications

S Kamata, and T Matsunaga, and K Uchida, and K Uchida
October 1965, Berliner und Munchener tierarztliche Wochenschrift,
S Kamata, and T Matsunaga, and K Uchida, and K Uchida
June 1985, Chemioterapia : international journal of the Mediterranean Society of Chemotherapy,
S Kamata, and T Matsunaga, and K Uchida, and K Uchida
March 2006, Biocontrol science,
S Kamata, and T Matsunaga, and K Uchida, and K Uchida
January 1996, Antimicrobial agents and chemotherapy,
S Kamata, and T Matsunaga, and K Uchida, and K Uchida
February 1983, Journal of medical microbiology,
S Kamata, and T Matsunaga, and K Uchida, and K Uchida
February 1992, Diagnostic microbiology and infectious disease,
S Kamata, and T Matsunaga, and K Uchida, and K Uchida
January 1996, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
S Kamata, and T Matsunaga, and K Uchida, and K Uchida
October 1991, Nihon rinsho. Japanese journal of clinical medicine,
S Kamata, and T Matsunaga, and K Uchida, and K Uchida
January 1980, Clinical therapeutics,
S Kamata, and T Matsunaga, and K Uchida, and K Uchida
August 2023, Research in veterinary science,
Copied contents to your clipboard!